UNH 📈 UnitedHealth Group - Overview

Exchange: NYSE • Opening Hours • Country: United States • Currency: USD • Type: Common Stock • ISIN: US91324P1021

UNH: Health, Insurance, Pharmacy, Software, Consulting, Wellness, Benefits

UnitedHealth Group Incorporated is a leading healthcare company in the United States, operating through four distinct segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

The UnitedHealthcare segment is focused on providing a range of health benefit plans and services to various customer groups, including national employers, public sector employers, mid-sized employers, small businesses, and individuals. This includes health care coverage, health and well-being services, Medicaid plans, children's health insurance, and health care programs for individuals aged 50 and older. Additionally, the segment offers health and dental benefits, hospital and clinical services, and health care benefits products to state programs that cater to the economically disadvantaged, medically underserved, and those without employer-funded health care coverage.

The Optum Health segment is dedicated to providing care delivery, care management, wellness, and consumer engagement services to patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. This segment focuses on improving health outcomes, reducing costs, and enhancing the overall patient experience.

The Optum Insight segment offers a range of software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. This segment helps clients navigate the complex healthcare landscape, optimize their operations, and make data-driven decisions.

The Optum Rx segment provides comprehensive pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities. This segment also develops programs in areas such as step therapy, formulary management, drug adherence, and disease/drug therapy management, aimed at improving patient outcomes and reducing healthcare costs.

Founded in 1974, UnitedHealth Group Incorporated is headquartered in Minnetonka, Minnesota, and is a pioneer in the healthcare industry, committed to improving the health and well-being of individuals and communities.

Additional Sources for UNH Stock

UNH Stock Overview

Market Cap in USD 531,004m
Sector Healthcare
Industry Healthcare Plans
GiC SubIndustry Managed Health Care
TER 0.00%
IPO / Inception 1984-10-26

UNH Stock Ratings

Growth 5y 87.1
Fundamental 37.2
Dividend 58.0
Rel. Performance vs Sector -0.01
Analysts 4.54/5
Fair Price Momentum 631.25 USD
Fair Price DCF 368.16 USD

UNH Dividends

Dividend Yield 12m 1.33%
Yield on Cost 5y 3.03%
Dividends CAGR 5y 11.98%
Payout Consistency 95.14%

UNH Growth Ratios

Growth Correlation 3m -7.2%
Growth Correlation 12m 56%
Growth Correlation 5y 89.1%
CAGR 5y 17.97%
CAGR/Mean DD 5y 3.12
Sharpe Ratio 12m 0.41
Alpha vs SP500 12m -16.70
Beta vs SP500 5y weekly 0.90
Volatility GJR Garch 1y 29.63%
Current Volume 3928.8k
Average Volume 20d 3165.5k
What is the price of UNH stocks?
As of November 21, 2024, the stock is trading at USD 600.50 with a total of 3,928,765 shares traded.
Over the past week, the price has changed by -0.89%, over one month by +5.08%, over three months by +3.79% and over the past year by +13.93%.
Is UnitedHealth Group a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, UnitedHealth Group (NYSE:UNH) is currently (November 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.20 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UNH as of November 2024 is 631.25. This means that UNH is currently overvalued and has a potential downside of 5.12%.
Is UNH a buy, sell or hold?
  • Strong Buy: 19
  • Buy: 5
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
UnitedHealth Group has received a consensus analysts rating of 4.54. Therefor, it is recommend to buy UNH.
What are the forecast for UNH stock price target?
According to ValueRays Forecast Model, UNH UnitedHealth Group will be worth about 694.5 in November 2025. The stock is currently trading at 600.50. This means that the stock has a potential upside of +15.65%.
Issuer Forecast Upside
Wallstreet Target Price 623.9 3.9%
Analysts Target Price 558.2 -7%
ValueRay Target Price 694.5 15.7%